Filter your search
- $3,995.00 – $7,990.00European Medical Device MarketsEuropean Medical Device Markets provides market size estimate and forecast to 2022 for the European market and individual country revenues, including Germany, France, UK, Italy, Spain, Sweden, Switzerland, and others; an examination of bellwether device companies; revenues for specific categories of medical devices; a look at market drivers and limiters; and competitive […]January 2, 2018$2,640.00 – $5,280.00Bundle of report sections including Molecular Assay Procedures Inherited Disease Markets Cancer MarkersDecember 20, 2017$2,000.00 – $4,000.00Expected High Growth Market Segments in Molecular Diagnostic Testing Tests for hepatitis, nucleic acid blood testing and respiratory testing are among the fast-growing segments of molecular testing in 2018, according to a new report from Kalorama Information. will exceed the average for revenue growth in molecular IVD, according to a new Kalorama Information report. Average […]December 14, 2017$2,000.00 – $4,000.0050 Key Biopharmaceutical and Biotechnology Companies Biopharmaceutical companies bring to market products that hold great promise for treating some of the most intractable medical conditions such as cancer and autoimmune disease. Biotech opportunities largely mirror those in the pharmaceutical industry. The key difference is that biotech firms are much more focused on research because they […]December 12, 2017$1,200.00 – $2,400.00Human Microbiome Applications in IVD and Other Healthcare Human Microbiome Applications in IVD and Other Healthcare examines the growing interest in the human microbiome in in vitro diagnostics and other healthcare applications. This report notes IVD company interest in the microbiome, including selected microbiome-based tests, including selected molecular tests; microbiome-based diagnostic biomarkers; and precision or […]December 6, 2017$3,600.00 – $7,200.00Estimating Market Size, Market Share, and Market Opportunity for Biopharmaceutical Contract Manufacturing Organizations Over the past several years, an unprecedented number of blockbuster drugs have lost patent protection, and this trend is expected to continue through the foreseeable future. Yet pharmaceutical companies cannot always produce their needed pipeline in-house. This has created an ideal […]November 29, 2017$3,600.00 – $7,200.00Next-Generation Sequencing Trends: Kalorama Survey of Laboratories Next-Generation Sequencing Trends: Kalorama Survey of Laboratories identifies some of the key changes taking place with both next-generation sequencing (NGS) systems in relation to their usage in labs and in relation to the sequencing of clinical samples for diagnostic or clinical research purposes. The report surveys the following […]November 21, 2017$3,600.00 – $7,200.00Biosimilars: Global Market, Trends and Competitor Analysis Biosimilars: Global Market, Trends, and Competitor Analysis is a detailed analysis both of the market for biosimilars and for the market effects on pharmaceutical markets. The report provides a complete picture of the biosimilars market, including information on the world, United States, EU, Germany, France, UK, Italy Spain, […]November 14, 2017$760.00 – $1,600.00This Kalorama Information report covers the market for virtual reality and augmented reality systems related to medical education and training. The market for virtual reality (VR) and augmented reality (AR) products and services in medical education and healthcare training is predominately based in surgical simulators. Virtual reality and augmented reality technology has developed into a […]November 9, 2017$2,000.00 – $4,000.00Cancer Liquid Biopsy Market Assessment (Breast Cancer, Colorectal Cancer, Lung Cancer, Ovarian Cancer, Pancreatic Cancer) The term liquid biopsy encompasses various diagnostic methods that use liquid, non-tissue specimens to provide information that can aid in the diagnosis, treatment and monitoring of cancer. Currently, tissue biopsies, along with imaging techniques, are the standard methods used in […]November 8, 2017